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Abstract
Objective: The objective of this survey was to study the association between Helicobacter pylori
infection and the severity of coronary atherosclerosis.
Methods: The study population consisted of 961 consecutive patients (711 males and 250 females)
who underwent coronary angiography for suspected or known coronary atherosclerosis. The
patients' body mass index, blood pressure, the blood lipid, blood glucose, leukocyte count (109/L),
neutrophil count (109/L), and Helicobacter pylori-specific IgG antibodies were performed.
Coronary angiograms were scored according to vessel score and Gensini's score.
Results: A significant association between H. pylori infection and coronary atherosclerosis as well
as its severity was not find in this cross section study (p = 0.858). And, the level distribution of
vessel score (p = 0.906) and Gensini's score (p = 0.905) were similar in the seropositivity group
and seronegativity group of Helicobacter pylori infection. However, the level of fasting high-density
lipoprotein cholesterol (mmol/L) (p = 0.013) was significantly lower in the seropositivity group than
that in the seronegativity group of Helicobacter pylori infection.
Conclusions: In conclusion, in the present study, a significantly correlation between Helicobacter
pylori seropositivity and angiographically evaluated severity of atherosclerosis was not find. And, the
present study showed a good correlation between Helicobacter pylori infection and decreased HDL
cholesterol. However, the exact mechanisms need further study.
Introduction
Cardiovascular diseases, including coronary atherosclero-
sis remain the leading cause of deaths in the developed
and developing countries despite of declining mortality.
Understanding the etiology and pathophysiology of coro-
nary atherosclerosis is essential in treating the disease and
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prevent its subsequent consequences, such as myocardial
infarction, and stroke. Coronary atherosclerosis is a mul-
tifactorial process where chronic inflammation plays a
pivotal role, while other risk factors such as dyslipidemia
also contribute to the pathogenesis of atherosclerosis
[1,2]. It has been reported that the inflammation plays an
important role in the initiation and progression of athero-
sclerosis and its complications [3]. A number of seroepi-
demiologic studies have suggested that there is an
association between coronary atherosclerosis and several
infectious agents, including those intracellular pathogens
such as Helicobacter pylori and Chlamydia pneumoniae [4].
H. pylori is a bacterium that commonly colonizes the
human stomach and causes chronic and active gastritis,
peptic ulcer disease and is associated with increased risk of
developing gastric cancer. Over the past decade, several
studies have demonstrated that H. pylori infection is asso-
ciated with the development of coronary atherosclerosis,
and suggested a causal relationship although this issue is
still controversial [5-10]. However, the mechanisms how
H. pylori infection results in the coronary atherosclerosis,
and the relationship between H. pylori infection and clin-
ical and laboratory risk factors including blood pressure,
smoking, blood glucose and lipids have not been fully
understood. Moreover, it is unknown whether H. pylori
infection is associated with the severity of coronary
atherosclerosis. Therefore, the present cross-sectional
study of 961 consecutive patients with angiographically
confirmed coronary atherosclerosis was carried out to
determine the association of H. pylori infection with any
of the above clinical and laboratory risk factors and the
severity of coronary atherosclerosis.
Materials and methods
Study subjects
From February 2004 to May 2006, consecutive adult
patients with coronary atherosclerosis as confirmed by
coronary angiography at the First Affiliated Hospital of
Nanjing Medical University, Nanjing, China, were
included in the study. Patients with spastic angina pec-
toris (i.e., acetylcholine-positive), infectious processes
within 2 weeks prior to the catheterization, heart failure
(Killip Class = 2) after acute myocardial infarction,
hepatic dysfunction, vascular disease (aortitis treated with
prednisolone), familial hypercholesterolemia, thyroid
dysfunction, or adrenal dysfunction were excluded.
This study was approved by the Ethics Committee of the
First Affiliated Hospital of Nanjing Medical University
and informed consent was obtained from each patient.
Coronary angiography
Coronary arteries were cannulated by the Judkins tech-
nique [11] with 5F catheters, and recorded on Kodak 35-
mm cine film at a rate of 30 frames per second. When
stenotic coronary arteries were found, a direct intracoro-
nary injection of isosorbide dinitrate (2.5 mg/5 ml solu-
tion over 20 s) was performed, and the presence of
stenosis was determined one minute after the injection by
coronary angiography from several projections with help
of a computer-assisted coronary angiography analysis sys-
tem (Mipron 1; Kontron Co. Tokyo, Japan).
Scoring of coronary angiogram
Coronary angiograms were scored according to vessel
score and Gensini's score: Vessel score: This was the
number of vessels with a significant stenosis (50% or
greater reduction in lumen diameter). Scores ranged from
0 to 4, depending on the number of vessels involved. Left
main artery stenosis was scored as single-vessel disease.
Gensini's score: The Gensini's score system is based on the
hypothesis that the severity of coronary heart disease
should be considered as a consequence of the functional
significance of the vascular narrowing and the extent of
the area perfused by the involved vessel or vessels. Based
on the system, a Gensini score was computed by assigning
a severity score to each coronary stenosis according to the
degree of luminal narrowing and its geographic impor-
tance. Reduction in the lumen diameter, and the roentge-
nographic appearance of concentric lesions and eccentric
plaques were evaluated (reductions of 25%, 50%, 75%,
90%, 99%, and complete occlusion were given Gensini
scores of 1, 2, 4, 8, 16, and 32, respectively). Each princi-
pal vascular segment was assigned a multiplier in accord-
ance with the functional significance of the myocardial
area supplied by that segment: i.e. × 5 for the left main
coronary artery, × 2.5 for the proximal segment of left
anterior descending coronary artery (LAD), × 2.5 for the
proximal segment of the circumflex artery, × 1.5 for the
mid-segment of the LAD, × 1.0 for the right coronary
artery, the distal segment of the LAD, the posterolateral
artery, and the obtuse marginal artery, and × 0.5 for any
others arteries [12].
Anthropometric measurements
Anthropometric measurements were performed after the
patients removed their shoes and upper garments and
wore an examination gown. Height was measured to the
nearest 0.1 cm using a wall-mounted stadiometer. Weight
was measured to the nearest 0.1 kg using a hospital bal-
ance beam scale. Body mass index (BMI) was calculated as
weight (kg) divided by the square of height (m2). Blood
pressure was measured in the right arm with the partici-
pant seated and the arm bared, and three measurements
were recorded for each individual, and the average was
used as the reading.
Detection of H. pylori-specific IgG antibodies
Serum samples were prepared from each of the partici-
pants.  H. pylori-specific IgG antibodies were measuredLipids in Health and Disease 2009, 8:59 http://www.lipidworld.com/content/8/1/59
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with the Assure(r) H. pylori Rapid Test with a current infec-
tion marker (CIM-test, Genelabs Diagnostics Pty Ltd, Sin-
gapore), which has been shown to have sensitivity,
specificity, positive and negative predictive values, and
accuracy of 93.2%, 90.5%, 94.9%, 87.5%, and 92.3%,
respectively, in Chinese [13]. Briefly, CIM test was
brought to room temperature from a 4°C freezer shortly
before use. One drop of sample was placed on the test
area. When the sample diffused across the membrane and
touched the pink indicator line, Chase Buffer was added
to the oval well and the tab marked "Hp" was pulled. The
result was then interpreted in 15 minutes. The absence of
the "A" band, which is a control line, indicated an invalid
result. Two bands present both at the positions "B" and
"C" (even faint) were suggestive of current infection and
only one band present at the position "C" indicated previ-
ous exposure. All samples were tested by an investigator
who was blinded to the results of the coronary angiogra-
phy.
Laboratory measurements
The total cholesterol (TCH), triglyceride (TG), fasting
blood glucose (FBG), fasting high-density lipoprotein
cholesterol (HDL-c), fasting low-density lipoprotein cho-
lesterol (LDL-c) were determined by enzymatic proce-
dures on an automated autoanalyzer (AU 2700 Olympus,
1st Chemical Ltd, Tokyo, Japan).
Hematological measurements
Blood samples from every patient were drawn at admis-
sion to the coronary unit and the measurements including
total leukocyte count (109/L), neutrophil count (109/L),
were performed by the automated blood analyzer.
Statistical analysis
Data analysis was performed by using the Statistical Pack-
age for Social Science (SPSS for Windows, version 10.0,
1999, SPSS Inc, Chicago, IL). Patients were classified into
four groups according to the Gensini's scores (using the
quartile values as cut-off points so that each group had an
about equal number of patients to minimize any bias that
may have been produced in the statistical analysis) and
vessel score. In addition, patients were classified into two
groups according to the status of H. pylori infection. Data
of BMI was normally distributed and thus presented as
mean ± standard deviation (SD) and comparisons were
analyzed by the independent-sample T test and the one-
way analysis of variance (ANOVA), whereas skewed data
including age, systolic blood pressure (SBP, mmHg),
diastolic blood pressure (DBP, mmHg), TG, FBG, TCH,
HDL-c, LDL-c, leukocyte count (109/L), neutrophil count
(109/L), vessel score and Gensini's scores were expressed
as median and/or quartile ranges, and comparisons were
analyzed by the Mann-Whitney U test or the Kruskal-Wal-
lis test, where appropriate. Categorical variables including
gender and H. pylori infection status were compared
between the groups of patients by chi-squared analysis.
Differences were considered to be statistically significant if
the null hypothesis could be rejected with >95% confi-
dence. All P values are 2-tailed.
Results
Demographical clincial and biochemical characteristics of 
study subjects
A total of 961 patients (711 males and 250 females, with
a median (range) age of 63 (54~70 years) were enrolled in
the study. The age, clinical and biochemical characteristics
of these patients are shown in Table 1.
Generally, SBP (P = 0.003), the levels of blood TCH (P <
0.001), HDL-c (P < 0.001), and LDL-c (P < 0.001) were
significantly higher in females than those in males sub-
jects. However, the level of leukocyte count (109/L) (P <
0.001), neutrophil count (109/L) (P < 0.001), vessel score
(P < 0.001) and Gensini's score (P < 0.001) were signifi-
cantly higher in males than those in female subjects. Of
the patients, 596 patients (62.0%) were seropositive for
H. pylori infection. The seropositivity rate was not signifi-
cantly different between males (61.9%) and females
(62.4%).
Demographical, clinical and biochemical characteristics in 
patients according to Gensini's scores
Gensini scores ranged from 0 to 276.0, with a median
(quartile ranges) of 20.0 (2.0-58.0), and vessel score
ranged from 0 to 4, with a median (quartile ranges) of
1.00 (0.00-2.00). Table 2 and Table 3 show the demo-
graphical, clinical and biochemical characteristics in
patients according to vessel score and Gensini's score. The
frequency distribution of the gender differed significantly
among the 4 groups (P < 0.001). Moreover, leukocyte
count (109/L) (P < 0.001), neutrophil count (109/L) (P <
0.001), age (P < 0.001) and glucose (P  < 0.001) were
increased with the increase of vessel score and Gensini's
score. And, HDL-c (P < 0.001) was decreased with the
increase of vessel score and Gensini's score. However,
BMI, SBP, DBP, TCH, triglyceride, and LDL-c did not
change following the increase of the vessel score and
Gensini's score (Table 2 and Table 3),
Associations of H. pylori infection with demographical, 
clinical and biochemical variables and the severity of 
coronary atherosclerosis in patients with coronary 
atherosclerosis
Table 4 shows the associations of H. pylori infection with
clinical and biochemical variables and the severity of cor-
onary atherosclerosis in patients. There was no difference
in the gender distribution and the age between H. pylori
positive and negative patients. BMI, SBP, DBP, TCH, trig-
lyceride, blood glucose, LDL-c, leukocyte count (109/L),Lipids in Health and Disease 2009, 8:59 http://www.lipidworld.com/content/8/1/59
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neutrophil count (109/L) were also similar between the
two groups. However, the level of HDL-c was significantly
lower in the seropositive patients than in the seronegativ-
ity group (0.97 mmol/L vs.1.02 mmol/L, P  = 0.013)
(Table 3). There was no significant deference in the posi-
tive rate among patients with different vessel score and
Gensini's score; in other words, there was no significant
association between H. pylori infection and the severity
coronary atherosclerosis (Tables 2, 3, 4).
Discussion
The role of inflammation mechanism in the pathogenesis
and progression of coronary artery disease has been
increasingly explored, but still remains to be elucidated.
Epidemiological studies based on serological findings
have suggested an association between chronic H. pylori
infection and atherosclerosis, although controversies exist
[8,14,15].
A few studies explored the association between H. pylori
infection and the clinical and biochemical variables in
patients with atherosclerosis. The present study showed
that HDL-c was significantly decreased in patients with H.
pylori  infection, indicating that H. pylori infection may
resulted in decreased blood HDL-c levels, which then con-
tributes to the development of coronary atherosclerosis.
H. pylori infection has been suggested to influence the
development of atherosclerotic changes in coronary arter-
ies, indicating a damaging effect of this bacterium or its
products (e.g. cytokines, endotoxins, cytotoxins and other
Table 1: Demographical and clinical and blood biochemical characteristics of the study subjects in relation to gender
Variables Male (n = 711) Female (n = 250) Total (n = 961) T or ZP
Age (year) 63.00 (53.00-70.00) 64.00 (56.00-70.00) 63.00 (54.00-70.00) -1.551 0.121
BMI(Kg/M2) 24.98 ± 3.01 24.76 ± 3.35 24.79 ± 3.39 0.788 0.431
SBP(mmHg) 130.00 (120.00-140.00) 138.00 (120.00-150.00) 130.00 (120.00-140.00) -2.951 0.003
DBP(mmHg) 80.00 (70.00-85.00) 80.00 (70.00-85.00) 80.00 (70.00-85.00) -0.672 0.502
Cholesterol (mmol/L) 3.96(3.40-4.47) 4.40(3.91-4.99) 4.07(3.49-4.60) -7.300 0.000
Triglyceride (mmol/L) 1.37(0.98-2.00) 1.52(1.11-2.14) 1.41(1.00-2.02) -1.905 0.057
Glucose (mmol/L) 4.75(4.31-5.48) 4.78(4.39-5.39) 4.77(4.34-5.48) -0.914 0.361
HDL-c (mmol/L) 0.94(0.81-1.09) 1.12(0.97-1.29) 0.98(0.84-1.16) -9.175 0.000
LDL-c (mmol/L) 2.29(1.87-2.76) 2.50(2.05-3.05) 2.36(1.90-2.84) -4.286 0.000
Leukocyte count (109/L), 6.50(5.30-8.30) 5.90(5.10-7.00) 6.30(5.20-8.00) -4.398 0.000
Neutrophil count (109/L) 3.99(3.03-5.48) 3.37(2.77-4.30) 3.80(2.97-5.12) -5.505 0.000
HP (+/-) 440/271 156/94 596/365 0.021 0.885
vessel score 1.00 (0.00-3.00) 1.00 (0.00-2.00) 1.00 (0.00-2.00) -5.103 0.000
Gensini's Score 25.00(4.00-64.00) 8.00(0.00-40.00) 20.00(2.00-58.00) -5.318 0.000
Table 2: Age and clinical and biochemical characteristics in patients grouped according to vessel score
Variables Vessel score F or Chi-Square P
0 (n = 324) 1 (n = 239) 2 (n = 175) 3 and 4 (n = 223)
Age (year) 60.00 (52.00~67.00) 59.50 (50.00~69.00) 66.00 (57.00~72.00) 68.00 (62.00~72.00) 78.213 0.000
BMI (Kg/M2) 25.19 ± 3.20 24.79 ± 3.11 24.75 ± 2.92 24.75 ± 3.08 1.298 0.274
SBP (mmHg) 130.00
(120.00~140.00)
130.00
(120.00~140.00)
130.00
(120.00~140.00)
130.00
(120.00~150.00)
5.610 0.132
DBP (mmHg) 80.00(70.00~90.00) 80.00(70.00~85.00) 80.00(70.00~85.00) 80.00(70.00~80.00) 6.094 0.107
Cholesterol (mmol/L) 4.09(3.51~4.53) 4.01(3.36~4.66) 4.08(3.42~4.61) 4.09(3.63~4.65) 1.704 0.636
Triglyceride (mmol/L) 1.44(0.99~2.05) 1.41(0.98~2.09) 1.38(0.94~1.99) 1.40(1.10~1.96) 0.528 0.913
Glucose (mmol/L) 4.66(4.29~5.17) 4.74(4.29~5.41) 4.84(4.40~5.61) 5.00(4.44~6.18) 23.548 0.000
HDL-c (mmol/L) 1.04(0.90~1.21) 0.99(0.82~1.11) 0.95(0.81~1.15) 0.94(0.81~1.11) 22.088 0.000
LDL-c (mmol/L) 2.31(1.92~2.76) 2.32(1.83~2.85) 2.31(1.81~2.99) 2.50(2.02~2.93) 6.451 0.092
Leukocyte count (109/
L),
5.7(4.85-6.80) 6.30(5.20-8.20) 6.40(5.50-8.50) 7.00(5.70-9.00) 63.422 0.000
Neutrophil count 
(109/L)
3.30(2.60-4.20) 3.90(3.10-5.30) 4.10(3.06-5.48) 4.34(3.30-6.23) 69.224 0.000
Gender (M/F) 209/115 180/59 135/40 185/38 26.801 0.000
H. pylori (+/-) 125/199 86/153 66/109 88/135 0.648 0.885Lipids in Health and Disease 2009, 8:59 http://www.lipidworld.com/content/8/1/59
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virulence factors) on the coronary endothelium [16]. In a
study of 470 healthy blood donors and 238 patients with
angiographically proven coronary heart disease, the mean
HDL-c concentration was significantly decreased in H.
pylori -positive healthy subjects compared with H. pylori -
negative subjects (1.36 vs. 1.44 mmol/L, P = 0.006) in
unadjusted analysis. In addition, the association between
H. pylori infection and decreased HDL-c persisted and
remained significant in multivariate linear regression
analysis (P = 0.002) [17]. This finding is further supported
by our present study. Therefore, it seems that chronic H.
pylori  infection results in decreased HDL-c levels, and
these lipid alterations could, at least in part, contribute to
the initiation and development of coronary atheroscle-
rotic diseases in H. pylori infected individuals. However,
the underlying mechanisms and potential pathogenic
pathways remained to be revealed.
In the present study, the seropositive rate for H. pylori
infection in the Chinese patients with coronary athero-
sclerosis is of 62.0%. This rate is close to the prevalence of
H. pylori infection in Chinese patients with dyspeptic
symptoms (65% reported in 1991 by Li et al [18], and
61% reported in 1995 by Zhou and Yang [19]), and in
individuals with a high gastric cancer risk (62% reported
in 2008 by Shi et al [20]) but higher than that reported in
healthy volunteers (49% reported in 1991 by Li et al [18],
and 43% reported in 1995 by Zhou and Yang [19]). In
2007, Chen et al reported that the age-specific seropreva-
lence of H. pylori infection had been decreased from 56%
Table 3: Age and clinical and biochemical characteristics in patients grouped according to Gensini's score
Variables Gensini's score F or Chi-Square P
~2.00 (n = 247) 2.01~20.00 (n = 234) 20.01~58.00 
(n = 238)
58.01~(n = 242)
Age (year) 58.00 (50.00~65.00) 63.00 (54.00~70.50) 64.00 (55.00~71.00) 66.00 (58.00~72.00) 54.883 0.000
BMI (Kg/M2) 25.30 ± 3.29 24.75 ± 2.92 24.74 ± 3.04 24.82 ± 3.11 1.811 0.144
SBP (mmHg) 130.00
(120.00~140.00)
130.00
(120.00~145.00)
130.00
(120.00~140.00)
130.00
(120.00~145.00)
4.494 0.213
DBP (mmHg) 80.00(70.00~90.00) 80.00(70.00~85.00) 80.00(70.00~85.00) 80.00(70.00~85.00) 5.152 0.161
Cholesterol (mmol/L) 4.04(3.51~4.46) 4.13(3.56~4.67) 4.09(3.44~4.69) 4.02(3.53~4.57) 2.810 0.422
Triglyceride (mmol/L) 1.44(0.99~2.00) 1.38(0.95~2.08) 1.45(1.08~2.07) 1.35(1.02~1.97) 1.767 0.622
Glucose (mmol/L) 4.66(4.29~5.17) 4.71(4.32~5.26) 4.84(4.27~5.54) 5.06(4.47~6.22) 28.978 0.000
HDL-c (mmol/L) 1.04(0.90~1.23) 1.03(0.87~1.17) 0.92(0.80~1.06) 0.96(0.82~1.12) 34.730 0.000
LDL-c (mmol/L) 2.29(1.89~2.72) 2.39(1.89~2.86) 2.32(1.87~2.98) 2.47(1.95~2.93) 3.193 0.363
Leukocyte count 
(109/L)
5.60(4.80-6.70) 6.05(5.10-7.38) 6.905.50(-8.50) 7.20(5.70-9.45) 78.189 0.000
Neutrophil count 
(109/L)
3.20(2.60-4.20) 3.52(2.60-4.50) 4.11(3.20-5.40) 4.60(3.29-6.83) 86.715 0.000
Gender (M/F) 157/90 166/68 188/50 198/44 26.359 0.000
H. pylori (+/-) 92/155 92/142 87/151 96/146 0.763 0.858
Table 4: Age and clinical and biochemical characteristics in patients grouped according to the status of helicobacter pylori infection
Variables Helicobacter pylori negative (n = 365) Helicobacter pylori positive(n = 596) T or ZP
Age (year) 64.00 (55.00-71.00) 62.50 (53.25-70.00) -1.245 0.213
BMI (Kg/M2) 25.15 ± 3.03 24.79 ± 3.15 1.697 0.090
SBP (mmHg) 130.00 (120.00-140.00) 13000 (120.00-145.00) -0.265 0.791
DBP (mmHg) 80.00 (70.00-85.00) 80.00 (70.00-85.00) -1.384 0.166
Cholesterol (mmol/L) 4.10(3.51-4.61) 4.05(3.49-4.58) -0.504 0.614
Triglyceride (mmol/L) 1.40(0.98-2.01) 1.42(1.01-2.06) -0.370 0.711
Glucose (mmol/L) 4.77(4.32-5.56) 4.77(4.37-5.43) -0.011 0.991
HDL-c (mmol/L) 1.02(0.86-1.19) 0.97(0.83-1.13) -2.494 0.013
LDL-c (mmol/L) 2.32(1.87-2.84) 2.37(1.93-2.84) -1.148 0.251
Leukocyte count (109/L) 6.20(5.18-7.93) 6.30(5.30-8.00) -0.812 0.417
Neutrophil count (109/L) 3.70(2.90-5.10) 3.83(3.00-5.20) -0.870 0.384
Gender(M/F) 271/94 440/156 0.021 0.885
vessel score 1.00(0.00-2.00) 1.00(0.00-2.00) -0.118 0.906
Gensini's Score 20.00(2.00-60.00) 20.50(2.00-57.00) -0.120 0.905Lipids in Health and Disease 2009, 8:59 http://www.lipidworld.com/content/8/1/59
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in 1993 to 47% in 2003 in healthy Chinese population in
Guangzhou city [21]. It is conceivable that the seroposi-
tive rate (62%) observed in patients with coronary athero-
sclerosis is higher than that in Chinese healthy
population, implying that H. pylori infection in patients
with coronary atherosclerosis is associated with the initia-
tion and development of coronary atherosclerosis. How-
ever, a healthy control group was not included in the
present study since the aim of the study was to determine
association of H. pylori infection with major biochemical
variables and severity of coronary atherosclerosis. Never-
theless, most previous epidemiological studies demon-
strated an association between H. pylori infection and
coronary atherosclerosis, suggesting a causal relation.
Therefore, we postulated that, in addition to the possible
role in the initiation of coronary atherosclerosis, chronic
H. pylori infection would accelerate the severity of the dis-
ease. However, another studies demonstrated that H.
pylori infection may not be an important factor in deter-
mining the risk of coronary artery disease [15,8], there is
no data on the association between H. pylori infection and
the severity of coronary atherosclerosis. In the present
study, a significantly association between H. pylori serop-
ositivity and angiographically evaluated severity of coro-
nary atherosclerosis was not revealed.
A few mechanisms may explain this finding. First, chronic
H. pylori infection may not play a role in the progression
of coronary atherosclerosis once the disease has been
induced. Second, the Gensini scores indicate the severity
degree of stenotic coronary lesion which occurs especially
in the late phase of coronary atherosclerosis, while the
inflammation following H. pylori infection contributes to
the early stage of atherosclerosis [22]. Therefore, indica-
tors other than Gensini scores may be also used in the
future studies on the association between H. pylori infec-
tion and the severity of coronary atherosclerosis. In addi-
tion, it has been reported in a meta-analysis that cagA
positive H. pylori strains that are more virulent than cagA
negative strains, are associated with an increased risk of
developing atherosclerotic diseases including both
ischemic stroke and coronary heart disease [23] However,
in the present study, cagA status was not determined, and
thus it is unknown whether cagA positive strains are asso-
ciated with the severity of the coronary atherosclerosis. As
described above, there are some limitations in the present
study. First, the present study is only a cross-sectional
study rather than a prospective, case-control study, and
thus the obtained findings cannot provide information
regarding the cause and effect relationship between H.
pylori infection and coronary atherosclerosis. Second, vir-
ulence factors of H. pylori such as cagA gene and H. pylori-
induced immune/inflammatory factors were not detected
in the present study, which does not allow further specu-
lation of the mechanisms how H. pylori infection may
contribute to the initiation and development of coronary
atherosclerosis. In conclusion, there is a significantly asso-
ciation between H. pylori seropositivity and decreased
blood HDL-c levels. However, an association between H.
pylori seropositivity and angiographically evaluated
severity of coronary atherosclerosis was not found.
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